Clicky

Insulet Corporation(GOV)

Description: Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.


Keywords: Diabetes Bluetooth Insulin Blood Glucose Monitoring Type 1 Diabetes Continuous Glucose Monitor Insulin Delivery Insulin Pump Insulin Dependent Diabetes Insulin Delivery Systems

Home Page: www.insulet.com

100 Nagog Park
Acton, MA 01720
United States
Phone: 978 600 7000


Officers

Name Title
Dr. James R. Hollingshead Ph.D. President, CEO & Director
Ms. Lauren Budden Group VP, Chief Accounting Officer & Controller
Mr. Mark Field Senior VP & CTO
Mr. John Wodick Kapples J.D. Senior VP & General Counsel
Mr. Eric Benjamin Executive VP, Chief Product & Customer Experience Officer
Ms. Ana Maria Chadwick Executive VP, CFO & Treasurer
Mr. Prem Singh Senior Vice President of Global Operations
June Lazaroff Senior Director of Investor Relations
Ms. Laetitia Cousin Senior VP of Regulatory Affairs, Quality Assurance & Compliance
Angela Geryak Wiczek Senior Director of Corporate Communications

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 68.9655
Trailing PE: 45.6577
Price-to-Book MRQ: 16.8292
Price-to-Sales TTM: 9
IPO Date:
Fiscal Year End: December
Full Time Employees: 3000
Back to stocks